Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Policies, adaptations, and ongoing challenges to naloxone, buprenorphine and nonprescription syringe access across four-states: Findings from an environmental scan and key informant interviews.
Floyd AS, Silcox J, Strickler G, Nong T, Blough M, Bolivar D, Rabin M, Bratberg J, Irwin AN, Hartung DM, Hansen RN, Bohler R, Green TC. Floyd AS, et al. Among authors: bolivar d. Drug Alcohol Depend Rep. 2024 May 28;11:100243. doi: 10.1016/j.dadr.2024.100243. eCollection 2024 Jun. Drug Alcohol Depend Rep. 2024. PMID: 38948428 Free PMC article.
Study protocol for the Respond to Prevent Study: a multi-state randomized controlled trial to improve provision of naloxone, buprenorphine and nonprescription syringes in community pharmacies.
Green TC, Bratberg J, Irwin AN, Boggis J, Gray M, Leichtling G, Bolivar D, Floyd A, Al-Jammali Z, Arnold J, Hansen R, Hartung D. Green TC, et al. Among authors: bolivar d. Subst Abus. 2022;43(1):901-905. doi: 10.1080/08897077.2021.2010162. Subst Abus. 2022. PMID: 35213293 Free PMC article.
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains.
Green TC, Silcox J, Bolivar D, Gray M, Floyd AS, Irwin AN, Hansen RN, Hartung DM, Bratberg J. Green TC, et al. Among authors: bolivar d. J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):71-78. doi: 10.1016/j.japh.2023.10.014. Epub 2023 Oct 18. J Am Pharm Assoc (2003). 2024. PMID: 37863398
Readiness of community pharmacies to implement an opioid safety intervention.
Floyd AS, Silcox J, Cousin E, Irwin AN, Gray M, Bolivar D, Bratberg J, Arnold J, Al-Jammali Z, Hansen RN, Hartung DM, Green TC. Floyd AS, et al. Among authors: bolivar d. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):275-283.e1. doi: 10.1016/j.japh.2022.10.031. Epub 2022 Nov 4. J Am Pharm Assoc (2003). 2023. PMID: 36496310 Free PMC article.
Implementation of an academic detailing intervention to increase naloxone distribution and foster engagement in harm reduction from the community clinician.
Irwin AN, Bratberg JP, Al-Jammali Z, Arnold J, Gray M, Floyd AS, Bolivar D, Hansen R, Hartung DM, Green TC. Irwin AN, et al. Among authors: bolivar d. J Am Pharm Assoc (2003). 2023 Jan-Feb;63(1):284-294.e1. doi: 10.1016/j.japh.2022.12.001. Epub 2022 Dec 7. J Am Pharm Assoc (2003). 2023. PMID: 36567216 Free PMC article. Clinical Trial.
15 results